Related Experiment Videos
Abnormal prothrombin in the vitamin K-deficient rat
Thrombosis Research
|August 15, 1984
Summary
Vitamin K deficiency in rats leads to undercarboxylated prothrombin, a key clotting factor. New assays confirm this abnormal protein is present at 5-10% of normal levels in deficient rat plasma.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Vitamin K is essential for synthesizing functional blood clotting factors.
- Vitamin K deficiency causes undercarboxylated clotting factors, impacting coagulation.
- The response of rat prothrombin to vitamin K interference was previously unclear.
Purpose of the Study:
- To quantify undercarboxylated prothrombin in vitamin K-deficient rats.
- To clarify the extent of vitamin K's role in rat prothrombin carboxylation.
Main Methods:
- Development of specific amidolytic and immunochemical assays for rat prothrombin.
- Analysis of plasma from vitamin K-deficient and Warfarin-treated rats.
Main Results:
- Vitamin K-deficient and Warfarin-treated rats exhibit undercarboxylated rat prothrombin.
- This abnormal prothrombin is non-BaSO4 adsorbable.
- The concentration of undercarboxylated prothrombin is 5-10% of normal plasma levels.
Conclusions:
- Vitamin K deficiency demonstrably affects rat prothrombin carboxylation.
- The developed assays provide a reliable method for assessing vitamin K status in rats.
- Findings resolve controversy regarding vitamin K-dependent clotting factor synthesis in rats.